Skip to main content
. 2021 Jul 4;31:102754. doi: 10.1016/j.nicl.2021.102754

Table 1.

Characteristics of participants.

CUn = 100 MCI-DLBn = 17 MCI-ADn = 41 P-valuea
Age, yrs 69.7 (9.4) 68.6 (5.6) 70.5 (8.7) 0.75
Males, no. (%) 72 (72%) 17 (100%) 25 (61%) 0.004
APOE4, no. (%) 32 (32%) 6 (35%) 28 (70%) <0.001
Education, yrs 15.3 (2.7) 16.2 (2.7) 16.1 (3.1) 0.20
CDR Sum of boxes 0.0 (0.1) 1.8 (1.0) 1.7 (1.1) <0.001
MMSE 28.7 (0.9) 27.7 (2.7) 26.0 (2.7) <0.001
Follow-up, yrs 3.2 (1.9) 2.0 (1.3) 0.08
UPDRS Part III 13.8 (12.1) 1.0 (2.3) <0.001
DRS Total 135.4 (6.6) 131.1 (7.6) 0.049
Visual Hallucinations, no. (%) 6 (35%) 0 (0%) <0.001
Fluctuations, no. (%) 7 (41%) 0 (0%) <0.001
Parkinsonism, no. (%) 14 (82%) 3 (7%) <0.001
RBD, no. (%) 15 (88%) 5 (12%) <0.001

Mean (SD) listed for the continuous variables and count (%) for the categorical variables. UPDRS Total and DRS Total values are not reported in the clinically unimpaired participants from the Mayo Clinic Study of Aging.

CU: clinically unimpaired. CDR: Clinical Dementia Rating Scale, MMSE: Mini-Mental State Examination, UPDRS: Unified Parkinson’s Disease Rating Scale (UPDRS), DRS: Mattis Dementia Rating Scale, pRBD: probable REM Sleep Behavior Disorder.

a

P-values represent an ANOVA test for continuous variables and Fisher’s exact test for categorical variables.